Chagas' disease

C Bern - New England Journal of Medicine, 2015 - Mass Medical Soc
Chagas’ Disease | New England Journal of Medicine Skip to main content The New England
Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology Clinical …

Chagas disease

JA Pérez-Molina, I Molina - The Lancet, 2018 - thelancet.com
Chagas disease is an anthropozoonosis from the American continent that has spread from
its original boundaries through migration. It is caused by the protozoan Trypanosoma cruzi …

Randomized trial of benznidazole for chronic Chagas' cardiomyopathy

CA Morillo, JA Marin-Neto, A Avezum… - … England Journal of …, 2015 - Mass Medical Soc
Background The role of trypanocidal therapy in patients with established Chagas'
cardiomyopathy is unproven. Methods We conducted a prospective, multicenter …

II Consenso Brasileiro em doença de Chagas, 2015

JCP Dias, AN Ramos Jr, ED Gontijo… - … e Serviços de …, 2016 - SciELO Public Health
RESUMO A doença de Chagas é uma condição crônica negligenciada com elevada carga
de morbimortalidade e impacto dos pontos de vista psicológico, social e econômico …

[HTML][HTML] 2 nd Brazilian Consensus on Chagas Disease, 2015

JCP Dias, AN Ramos Jr, ED Gontijo… - Revista da Sociedade …, 2016 - SciELO Brasil
Chagas disease is a neglected chronic condition with a high burden of morbidity and
mortality. It has considerable psychological, social, and economic impacts. The disease …

Randomized trial of posaconazole and benznidazole for chronic Chagas' disease

I Molina, J Gómez i Prat, F Salvador… - … England Journal of …, 2014 - Mass Medical Soc
Background Current therapeutic options for Chagas' disease are limited to benznidazole
and nifurtimox, which have been associated with low cure rates in the chronic stage of the …

Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial

CA Morillo, H Waskin, S Sosa-Estani… - Journal of the American …, 2017 - jacc.org
Background: Benznidazole is recommended for treatment of Chagas infection. Effects of
combination therapy with benznidazole and posaconazole have not been tested in …

Diagnosis and management of Chagas disease and cardiomyopathy

AL Ribeiro, MP Nunes, MM Teixeira… - Nature Reviews …, 2012 - nature.com
Chagas cardiomyopathy is the most severe and life-threatening manifestation of human
Chagas disease—a'neglected'tropical disease caused by the protozoan parasite …

Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for …

A Rassi Jr, JA Marin, A Rassi - Memórias do Instituto Oswaldo Cruz, 2017 - SciELO Brasil
Chagas cardiomyopathy is the most frequent and most severe manifestation of chronic
Chagas disease, and is one of the leading causes of morbidity and death in Latin America …

Antitrypanosomal therapy for chronic Chagas' disease

C Bern - New England Journal of Medicine, 2011 - Mass Medical Soc
Antitrypanosomal Therapy for Chronic Chagas' Disease | New England Journal of Medicine Skip
to main content The New England Journal of Medicine homepage Advanced Search SEARCH …